Nearly 9,000 employees worldwide after the spin-off · Worldwide employees after seed and genetics spin-off As of Oct 1, 2026 · Checked Oct 11, 2026 · Next source review Jan 9, 2027 · Source ↗
Indiana headcount
Not yet publicly verified
Scope and reporting notes
Seed and genetics business was successfully spun off October 1, 2026; this is a closed separation, not a proposed transaction.
FY2025 global count of approximately 21,500 predates the separation and must not be displayed as the current Corteva-only count.
The corporate investor homepage still displayed approximately 22,000 from its pre-separation company facts when checked; use the dated completion announcement for current scope.
Company-wide, Indiana, local and parent figures are shown separately. Reporting dates may be older than the date checked. Unavailable figures remain unverified.
Business overview
Corteva presents itself as a company shaped by innovation and a focus on customer outcomes, and states it builds on its heritage to address future challenges in crop protection. Source ↗
The company describes innovation as central to its scientific approach, combining multiple technical disciplines and partnerships to develop agricultural solutions and to prepare growers for evolving challenges. Source ↗
Products & services
Corteva says its innovation activities concentrate on four technical areas—disease control, insect and pest control, weed control, and improving plant performance—as part of developing field-focused solutions. Source ↗
Customers & markets
The company reports that it works directly with growers to understand field challenges and applies science, technology and data-driven insights to create solutions intended to improve outcomes on farms. Source ↗
Company background
Corteva's timeline on its website records corporate milestones including the spin-off from DowDuPont and historic entries tracing predecessor companies and activities that contributed to its evolution. Source ↗
Indiana connection
The company states that in 2022 Indianapolis was named as its new headquarters, relocating its corporate center closer to aspects of its operations, technology and customers. Source ↗
Summarized from the company’s official website. Information checked October 11, 2026.
Corteva, Inc. announced that it and Inari have reached a confidential settlement resolving the lawsuit filed by Corteva in September 2023 that was pending in the U.S. District Court for the District of Delaware. Corteva said Inari agreed to destroy Corteva material accessed from seed depositories and material developed from those deposits, assign to Corteva the intellectual property related to its edited versions of Corteva events, and negotiate certain licensing arrangements; other terms remain confidential.
Corteva announced that the SEC has declared effective Vylor’s Registration Statement on Form 10. The filing describes Vylor’s business, strategy and the planned separation into an independent, publicly traded company expected to be completed October 1, 2026. Corteva said each stockholder of record as of September 24, 2026 will receive one share of Vylor common stock per Corteva share, with the distribution expected prior to 9:30 a.m. New York time on October 1, 2026. Vylor is expected to begin trading on the NYSE under the symbol “VYLR.”
Corteva said Vylor — the advanced seed and genetics company that will spin off from Corteva on October 1, 2026 — and Belgium-based Rainbow Crops have announced a collaboration to accelerate development of corn hybrids using Rainbow Crops’ AI-supported Trait Foundry and multiplex gene editing. The companies said the work targets resilience to heat, drought and floods, aims to improve input efficiency and increase yield, and follows Corteva’s participation in Rainbow Crops’ €9.7 million seed financing round.
Corteva announced that it has entered into a definitive agreement with Globachem to form a 50/50 joint venture to develop and commercialize new formulated crop protection solutions for farmers in Europe and the Americas. The independently operated JV will leverage late-pipeline to commercial-stage technologies from both companies, may commercialize products through one or both parents, is expected to close in Q4 2026 subject to approvals, and anticipates new solution launches in the early 2030s, Corteva stated.
